Program for Saturday May 04, 2019

This webpage is displaying information from the 2019 AGS Annual Meeting, which was held in Portland, OR, May 2-4. Please check back at a later date for information regarding the upcoming 2020 Annual Meeting.



  • Date:
  • Time: 1:00pm - 2:00pm
  • Track: Clinical Practice
  • Location: Portland Ballroom 251 & 258
  • CME/CE: 1.0 - AMA Credits, AAFP Prescribed Credits, CMD Clinical Credits, Nursing Credits, Pharmacy Credits

Developed by the Pharmacists Section

Moderator: David P. Elliott, PharmD, BCGP

The goal of this session is for attendees to become familiar with pharmacotherapy advances that were made in the past year in addition to new safety updates for older medications.  Learning Objectives: (1) communicate the indication for use, mechanism of action, pharmacokinetics, dosing, safety, and drug interactions for newly approved medications; (2) compare potential advantages and disadvantages of incorporating new medications into clinical practice; (3) evaluate new drug safety updates, including new doses and indications, used in the care of older adults; and (4) discuss the ramifications of new safety data regarding drugs approved for use in the US with patients.

Newly Approved Medications and Place in Therapy for Older Adults 
Ashley M. Campbell, PharmD, BCPS

What's New with Old Drugs
Lisa C. Hutchison, PharmD, MPH, BCPS, BCGP



  • Date:
  • Time: 1:00pm - 2:00pm
  • Track: Ethics
  • Location: Portland Ballroom 253
  • CME/CE: 1.0 - AMA Credits, AAFP Prescribed Credits, CMD Clinical Credits, Nursing Credits, Pharmacy Credits

Sponsored by the Ethics Committee

Moderator: Elizabeth K. Vig, MD, MPH

Many working in health care have encountered a colleague who appears to have cognitive impairment, but continues to work. When faced with this situation, health care professionals may not know what to do, including identifying which interventions are ethically justifiable.  Learning Objectives: (1) identify three normal changes to cognition with aging that may impact a clinician's ability to work; (2) describe the pros/cons of mandatory aged-based cognitive screening; and (3) explain resources available to assess and help clinicians with cognitive impairment who continue to work.

Normative Cognitive Changes that Occur with Aging
Nicole D. Torrence, PhD

Whose Responsibility Is It To Do Something when a Working Clinician Has Cognitive Impairment?
Elizabeth K. Vig, MD, MPH

Approach of the WA Physicians Health Program
Chris Bundy, MD, MPH